VHI VALHI INC /DE/

Q3 2025 10-Q

Filed: Nov 6, 2025Period ending Sep 30, 2025

Health Care

Industrial Inorganic ChemicalsSEC EDGAR

VALHI INC /DE/ (VHI) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 6, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Management Discussion & Analysis

• No quarterly revenue or YoY change figures provided in the goodwill discussion
• No profitability or margin data disclosed in this section

+3 more insights

Risk Factors

• No new or changed risk factors disclosed since 2024 Annual Report risk section
• Most significant risks remain operational exposure in chemical markets and cyclicality of end markets

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$504M

Net Income

-$22M

Gross Margin

12.0%

Operating Margin

1.7%

Net Margin

-4.4%

ROE

-2.1%

Total Assets

$2.7B

Source: XBRL data from VALHI INC /DE/ Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on VALHI INC /DE/

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.